Anil Namboodiripad
Corporate Officer/Principal chez DR. REDDY'S LABORATORIES LIMITED
Profil
Anil Namboodiripad is currently the Chief Executive Officer at SCRIPT Biosciences, Inc. since 2021.
He is also the Global Head-Proprietary Products at Dr. Reddy's Laboratories Ltd.
since 2016.
Dr. Namboodiripad holds a doctorate degree from The University of Texas at Austin.
Postes actifs de Anil Namboodiripad
| Sociétés | Poste | Début |
|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01/12/2016 |
Script Biosciences, Inc.
 Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Chief Executive Officer | 01/01/2021 |
Formation de Anil Namboodiripad
| The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Technology Services |
